Cargando…

Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens

Detalles Bibliográficos
Autores principales:	Hanada, Ken-ichi, Chow, Christopher, Hoyos, Raul Gil, Gartner, Jared J, Prickett, Todd D, Somerville, Robert, Hogan, Katherine, Robbins, Paul F, Rosenberg, Steven A, Yang, James C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646102/ http://dx.doi.org/10.1186/2051-1426-3-S2-P20

Ejemplares similares

Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens
por: Parikh, Anup Y., et al.
Publicado: (2023)

Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing
por: Lu, Yong-Chen, et al.
Publicado: (2021)

Durable complete response in a patient with metastatic melanoma following adoptive transfer of autologous T cells recognizing 10 mutated tumor antigens
por: Prickett, Todd D, et al.
Publicado: (2015)

Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
por: Kim, Sanghyun P., et al.
Publicado: (2022)

Discovery and characterization of an immunogenic neoantigen in a patient with metastatic triple negative breast cancer
por: Assadipour, Yasmine, et al.
Publicado: (2015)

Adoptively transferred tumor-infiltrating T cells target somatic cancer mutations in a human papillomavirus+ cancer patient with complete tumor regression
por: Stevanović, Sanja, et al.
Publicado: (2015)

Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer
por: Deniger, Drew C, et al.
Publicado: (2015)

Unique neoantigens expressed by melanomas and common epithelial cancers presented by multiple HLA alleles can be efficiently identified utilizing peptide prediction algorithms
por: Trebska-Mcgowan, Kasia, et al.
Publicado: (2015)

Mining Exomic Sequencing Data to Identify Mutated Antigens Recognized by Adoptively Transferred Tumor-reactive T cells
por: Robbins, Paul F., et al.
Publicado: (2013)

Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma
por: Leko, Vid, et al.
Publicado: (2021)

Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
por: Crystal, Jessica S, et al.
Publicado: (2015)

Specific recognition of an FGFR2 fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma
por: White, Bradley Sinclair, et al.
Publicado: (2023)

Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors
por: Pan, Jenny H, et al.
Publicado: (2015)

Neoantigen-reactive CD8(+) T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
por: Kristensen, Nikolaj Pagh, et al.
Publicado: (2022)

Neoantigen vaccine: an emerging tumor immunotherapy
por: Peng, Miao, et al.
Publicado: (2019)

Neoantigens and their potential applications in tumor immunotherapy
por: Fang, Xianzhu, et al.
Publicado: (2022)

Use of CD137 up-regulation to identify T cell receptors specifically reactive with mutated tumor associated antigens from tumor infiltrating lymphocytes
por: Parkhurst, Maria, et al.
Publicado: (2015)

Cell surface marker-based capture of neoantigen-reactive CD8(+) T-cell receptors from metastatic tumor digests
por: Chatani, Praveen D, et al.
Publicado: (2023)

Neoantigen-specific CD4(+) tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
por: Hall, MacLean S., et al.
Publicado: (2023)

Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer
por: Hinrichs, Christian S, et al.
Publicado: (2013)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
por: Zhang, Zheying, et al.
Publicado: (2021)

pTuneos: prioritizing tumor neoantigens from next-generation sequencing data
por: Zhou, Chi, et al.
Publicado: (2019)

T cells of colorectal cancer patients’ stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells
por: Schwarz, Sandra, et al.
Publicado: (2022)

Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
por: Zhu, Yicheng, et al.
Publicado: (2021)

Adoptive cell therapy with tumour-infiltrating lymphocytes: the emerging importance of clonal neoantigen targets for next-generation products in non-small cell lung cancer
por: Robertson, Jane, et al.
Publicado: (2019)

T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
por: Sim, Malcolm J. W., et al.
Publicado: (2022)

Tumor neoantigens: Novel strategies for application of cancer immunotherapy
por: GUAN, HANYANG, et al.
Publicado: (2023)

Individual cultures of melanoma tumor infiltrating lymphocytes possess distinct patterns of reactivity with mutated antigens identified by whole exome sequencing of autologous tumors
por: Crystal, Jessica S, et al.
Publicado: (2014)

KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors
por: Lu, Dan, et al.
Publicado: (2023)

What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
por: Redwood, Alec J., et al.
Publicado: (2022)

Evolutionary dynamics of neoantigens in growing tumors
por: Lakatos, Eszter, et al.
Publicado: (2020)

MHC-II neoantigens shape tumor immunity and response to immunotherapy
por: Alspach, Elise, et al.
Publicado: (2019)

Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized Immunotherapy
por: Truex, Nicholas L., et al.
Publicado: (2020)

Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
por: Segura-Collar, Berta, et al.
Publicado: (2023)

A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
por: Jing, Zhe, et al.
Publicado: (2022)

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression
por: Nguyen, Kim Bich, et al.
Publicado: (2023)

Computational Prediction and Validation of Tumor-Associated Neoantigens
por: Roudko, Vladimir, et al.
Publicado: (2020)

Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors
por: Franzese, Ornella, et al.
Publicado: (2017)

Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
por: Segura-Collar, Berta, et al.
Publicado: (2023)

Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells
por: Pavoni, Emiliano, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ruui59mv48f4pajn8gthmqmos6